Numerous prospects in health technology say analysts
November 12, 2014Medical Communications, Sales and Marketing 3D, AstraZeneca, F&S, app, digital, frost and sullivan, fs, wearables
Medical devices and imaging technology have been included in a recent analysis of the top 50 most innovative technologies. Frost …
Dendreon files for bankruptcy
November 12, 2014Research and Development, Sales and Marketing Dendreon, Provenge, awick, delaware, johnson, nj
Dendreon Corporation, the troubled manufacturer of high-cost cancer vaccine Provenge, has filed for bankruptcy as a prelude to restructuring its …
NHS Better Care Fund lacks guidance, says watchdog
November 12, 2014Sales and Marketing England, NHS, UK, better care fund, nao
A much-lauded project to reduce unnecessary hospital visits and shift care into the community will fall well short of its …
Doctors warn of urgent care ‘chaos’
November 12, 2014Sales and Marketing BMA, GPs, NHS, doctors, nagpaul, pac
Doctors’ leaders are demanding greater investment in out-of-hours GP services, warning of ‘fragmentation’ and underfunding, and branding the current system …
Theorem appoints two vice presidents
November 12, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Angela Weston, Kathryn Bohannon, theorem
Contract research organisation Theorem has named Kathryn Bohannon as vice president of its biopharma development unit, and Angela Weston as …
Eisai: Fycompa decision ‘deeply regrettable’
November 11, 2014Research and Development, Sales and Marketing Eisai, Fycompa, Germany, epilepsy, gba, perampanel
Eisai has lashed out at a major German health assessment body, calling its stance on first-in-class epilepsy treatment Fycompa ‘deeply …
FDA decides on format for facility registrations
November 11, 2014Manufacturing and Production FDA, fdasia, gln, gs1, manufacturing, ufi
The US FDA has finalised the details of its registration scheme for pharma manufacturing facilities, which aims to make it …
GPs to ‘prescribe’ apps
November 11, 2014Medical Communications, Sales and Marketing Apple, Frost & Sullivan, GPs, NHS, Samsung, UK, apps, eHealth, prescribing
General practitioners in the UK are to begin ‘prescribing’ health apps as part of a move to better monitor issues …
AstraZeneca diabetes drug approved for use in Scotland
November 11, 2014Sales and Marketing Afinitor, AstraZeneca, Eylea, Onglyza, Perjeta, SMC, diabetes, type 2
The Scottish Medicines Consortium (SMC) has shown AstraZeneca’s Onglyza (saxagliptin) the green light to be used with insulin in patients …
inVentiv Health president joins from eBay
November 11, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing inVentiv Health, jeff wilks
Life sciences services company inVentiv Health has announced the appointment of Jeffrey Wilks as the president of its advertising businesses. …
UCB sells generics business
November 10, 2014Manufacturing and Production, Sales and Marketing Belgium, UCB, generics, kremers urban, us conern
UCB is to sell its US generics business Kremers Urban to two private equity firms in a $1.5 billion deal. …
Novartis to present inflammatory data
November 10, 2014Business Services AS, Novartis, PSA, Secukinumab, acr
Novartis is to present data from four pivotal Phase III trials in two debilitating inflammatory diseases at the American College …
BMS claims advance with hepatitis C regimen
November 10, 2014Research and Development, Sales and Marketing BMS, Gilead, HCV, dcv-trio, hep C, hepatitis C, liver, sovaldi
Bristol-Myers Squibb has reported data for its hepatitis C virus cocktail that it says outperforms even newer all-oral therapies in …
Working Life: Shire’s Mark Rus
November 10, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, Working Life, mark rus, neuroscience
How did you find your way into your current role? After completing an MSc in Economics at the London School …
Chief executive promotion at myoscience
November 10, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing jeffrey gold, myoscience
Californian medical device firm myoscience has appointed Jeffrey Gold as its chief executive. Gold who was the president and chief …
New editor for Pharmafocus named
November 7, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, lilian anekwe, pharmafile
Lilian Anekwe has been named as the new editor for the Pharmafocus and Pharmafile brands, and joins the publishing team …
EU and drug industry set aside €280m for Ebola
November 7, 2014Research and Development, Sales and Marketing Africa, Ebola, WHO, chan, vaccines, virus, west
The EU’s Innovative Medicines Initiative (IMI) has unveiled a new programme to find vaccines, drugs and diagnostics for Ebola, funded …
Doctors must help NHS save money, says report
November 7, 2014Medical Communications, Sales and Marketing Academy of Medical Royal Colleges, GPs, NHS, government, hospitals
A report has suggested the National Health Service could make nearly £2 billion in cost savings if doctors ‘provided more …
Perrigo acquires Omega for $4.5 billion
November 7, 2014Manufacturing and Production, Sales and Marketing Actavis, Boehringer Ingelheim, Boehringer Ingelheim., Elan, Perrigo, Sanofi, omega
In a deal worth $4.5 billion Perrigo has announced the acquisition of over-the-counter (OTC) drugmaker Omega. This places the Irish …
Why use a specialised mother-tongue translator?
November 7, 2014“Translation is that which transforms everything so that nothing changes.” Günter Grass The art of a good translation is to …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
